DOCSLIB.ORG

General Onefile Print

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
General Onefile Print Document View http://proquest.umi.com.myaccess.library.utoronto.ca/pqdlink?index=0&s... Databases selected: Multiple databases... Scientific giants of integrity; [ONT Edition] Eric Meslin . Toronto Star . Toronto, Ont.: Oct 5, 2005. pg. A.21 Abstract (Summary) Canadians James Till and Ernest McCulloch are more than just lab geniuses, The recent celebration of James Till and Ernest McCulloch's groundbreaking stem cell research in the early 1960s pays homage to two Canadian scientific giants, whose work went largely unnoticed by the general public until the pair were given a long overdue 2005 Lasker Award, North America's most coveted medical prize. I quickly learned what many other students and colleagues of his had learned over the decades This was a person who oozed ethical integrity from every pore of his body. Not the simple- minded kind of integrity that we still foolishly assume will prepare our students for careers in science - where they must learn the proper rules and procedures of the scientific process, of authorship, or the ethics review committee process. No, Till oozed the real stuff the type of integrity that can't be learned in a book. Canadians James Mill, above, and Ernest McCulloch, both from the University of Toronto, received the 2005 Lasker award for their groundbreaking work with stem cells. Canadians James Mill, above, and Ernest McCulloch, both from the University of Toronto, received the 2005 Lasker award for their groundbreaking work with stem cells. Full Text (803 words) (Copyright (c) 2005 Toronto Star, All Rights Reserved. ) Canadians James Till and Ernest McCulloch are more than just lab geniuses, The recent celebration of James Till and Ernest McCulloch's groundbreaking stem cell research in the early 1960s pays homage to two Canadian scientific giants, whose work went largely unnoticed by the general public until the pair were given a long overdue 2005 Lasker Award, North America's most coveted medical prize. The news reports went out of their way to report on this achievement with typical Canadian hubris; had their work been carried out south of the border, McCulloch and Till might have already been awarded a Nobel prize. Efforts also were made to compare their accomplishments to other, arguably more "famous" scientific duos, such as James Watson and Francis Crick who first explained the structure of DNA. McCulloch is quoted in one story as saying that the pair did not "seek celebrity." This is reminiscent (with apologies to Shakespeare) of that wonderfully humbling line in Twelfth Night and paraphrased here - some scientists are born great, some achieve greatness, and others have greatness thrust upon them. McCulloch and Till seem to have situated themselves squarely in the second category and for their accomplishments we Canadians are justifiably proud. But something important is missing from this story. As it is with much of science, society tends to learn about the successes (e.g., sequencing the genome or finding a new planet) or, in rare cases, the failures (e.g., patient deaths in a clinical trial or a case of scientific misconduct). But missing from the reports of the McCulloch/Till accomplishment was any sustained mention of the kind of scientists these men were and, more importantly, their approach to science and the pursuit of truth. I have never met McCulloch, but I had the opportunity in the late 1980s and early 1990s as a new assistant professor at the University of Toronto, to work with Till. By this time, Till had long since left the lab to begin investigating, with Heather Sutherland, how to measure "quality of life" experiences with cancer patients. As someone working in bioethics I had no prior knowledge of Till's work on stem cells, the most important of which occurred the year I was born. 1 of 2 7/27/2008 8:50 PM Document View http://proquest.umi.com.myaccess.library.utoronto.ca/pqdlink?index=0&s... But I quickly learned what many other students and colleagues of his had learned over the decades This was a person who oozed ethical integrity from every pore of his body. Not the simple- minded kind of integrity that we still foolishly assume will prepare our students for careers in science - where they must learn the proper rules and procedures of the scientific process, of authorship, or the ethics review committee process. No, Till oozed the real stuff the type of integrity that can't be learned in a book. If he were a subject of a moral philosopher's assessment, he might be described as a virtuous scientist, the type of researcher who can habitually be relied upon to do the right thing without being told what to do. The "right thing" applied to all phases of his work, from the initial conception of an idea, to the meticulous description of an outline of the idea, to working out the problem to the solved, designing and conducting an experiment, analyzing the data, writing up the results, and submitting them to a journal for publication. At each step, Till's integrity was on display. It may have been the smallest matter, such as the proper order of authorship, to the largest - the constructive criticism he would offer to help refine what you already thought was an exquisitely thought-through research question. I was privileged to publish four academic papers with him and each paper was better than the one before. In those few years, I got a small taste of what many before, and many still, are learning from him. These qualities of scientific rigour and ethical integrity make for a potent combination. Liberally sprinkled with an infectious laugh and sense of humour, there are few who can match Till's mentoring ability. So while we celebrate the scientific accomplishments, let us not forget that truly good science also involves good scientists. Sure, it would be nice to have more Canadians win Laskers and Nobels, but the true measure of Canadian greatness in science might also be measured by the number of students whose ethical integrity in science approaches that of people like Jim Till. Eric M. Meslin, Ph.D., is director of the Indiana University Center for Bioethics, and assistant dean at the IU School of Medicine in Indianapolis. [Illustration] Canadians James Mill, above, and Ernest McCulloch, both from the University of Toronto, received the 2005 Lasker award for their groundbreaking work with stem cells. Canadians James Mill, above, and Ernest McCulloch, both from the University of Toronto, received the 2005 Lasker award for their groundbreaking work with stem cells. Indexing (document details) Author(s): Eric Meslin Section: Opinion Publication title: Toronto Star. Toronto, Ont.: Oct 5, 2005. pg. A.21 Source type: Newspaper ISSN: 03190781 ProQuest document ID: 906746951 Text Word Count 803 Document URL: http://proquest.umi.com.myaccess.library.utoronto.ca/pqdlink?did=906746951&sid=18&Fmt=3&c lientId=12520&RQT=309&VName=PQD Copyright © 2008 ProQuest LLC. All rights reserved. 2 of 2 7/27/2008 8:50 PM Document View http://proquest.umi.com.myaccess.library.utoronto.ca/pqdweb?index=3&s... Databases selected: CBCA Business, CBCA Current Events, CBCA Education, CBCA Reference RSC/2005 Centenary Medal Awarded to Co-winners of Lasker Award: Ernest A. McCulloch & James E. Till CCNMatthews Newswire . Toronto: Oct 27, 2005. pg. 1 Abstract (Summary) [Ernest A. McCulloch], FRSC, and [James E. Till], FRSC, of the Ontario Cancer Institute are the 2005 recipients of the Centenary Medal of the Royal Society of Canada celebrating the continued contributions their research has made to stem cell research. Co-winners of the 2005 Albert Lasker Award for Basic Research, Drs. McCulloch and Till are recognized for their revolutionary research in experimental haematology. Their most prominent discovery, that of hemopoietic stem cells in 1961, was rapidly followed by a classic set of papers describing their nature and the genetics that control these cells. Full Text (287 words) Copyright CCNMatthews Oct 27, 2005 OTTAWA, ONTARIO--(CCNMatthews - Oct. 27, 2005) - Ernest A. McCulloch and James E. Till will be presented the 2005 Centenary Medal, one of the prestigious honours of the RSC: The Academies of Arts, Humanities and Sciences of Canada. The Centenary Medal was created in 1982 to honour individuals and organizations who have made outstanding contributions to the object of the Society and to recognize links to international organizations. Those who received it during the centenary celebrations of the Society are listed in the Proceedings for 1982. Since then the medal has been awarded by decisions in Council, at irregular intervals, in recognition of exceptional achievements in scholarship and research. Ernest A. McCulloch, FRSC, and James E. Till, FRSC, of the Ontario Cancer Institute are the 2005 recipients of the Centenary Medal of the Royal Society of Canada celebrating the continued contributions their research has made to stem cell research. Co-winners of the 2005 Albert Lasker Award for Basic Research, Drs. McCulloch and Till are recognized for their revolutionary research in experimental haematology. Their most prominent discovery, that of hemopoietic stem cells in 1961, was rapidly followed by a classic set of papers describing their nature and the genetics that control these cells. From this work they developed detailed studies of the nature of leukemia leading in turn to contributions on other forms of cancer and the care of those afflicted with the disease. Throughout, their scientific careers have been illuminated by unswerving efforts to serve the community and promote the highest ideals of health care. The Centenary Medal will be presented to Drs. McCulloch and Till at a special event to be held in Toronto at a later date. Details regarding this event will be communicated shortly.
Load more

Recommended publications
  • The Early History of Medical Genetics in Canada William Leeming OCAD University [email protected]
    OCAD University Open Research Repository Faculty of Liberal Arts & Sciences and School of Interdisciplinary Studies 2004 The Early History of Medical Genetics in Canada William Leeming OCAD University [email protected] © Oxford University Press. This is the author's version of the work. It is posted here for your personal use. Not for redistribution. Original source at DOI: 10.1093/shm/17.3.481. Recommended citation: Leeming, W. “The Early History of Medical Genetics in Canada.” Social History of Medicine 17.3 (2004): 481–500. Web. Leeming, W. (2004). The early history of medical genetics in Canada. Social History of Medicine, 17(3), 481-500. Pre-Publication Draft The Early History of Medical Genetics in Canada Abstract: This article shows that the intellectual and specialist movements that supported the growth of medical genetics in Canada between 1947 and 1990 were emergent phenomena, created, split, and reattached to different groups of actors, and reconfigured numerous times over the course of four decades. In each instance, new kinds of working relationships appeared; sets of diverse actors in local university- hospital settings coalesced into a new collectivity; and, as a collectivity, actors defined and/or redefined occupational roles and work rules. In its beginnings, medical genetics appears to be the object of a serious institutional manoeuver: a movement in support of the creation of examining and teaching positions in human genetics in North American medical schools. With time, the institutionalization of ‘medical genetics’ took hold, spurred on by changes in the rate and direction of service delivery associated with genetic consultation and laboratory services in clinical settings.
    [Show full text]
  • Universidad Autónoma De Madrid
    UNIVERSIDAD AUTÓNOMA DE MADRID DEPARTAMENTO DE BIOLOGÍA MOLECULAR Identification and functional characterization of epigenetic determinants of pancreatic CSCs Sladjana Zagorac Madrid, 2015 DEPARTAMENTO DE BIOLOGÍA MOLECULAR FACULTAD DE CIENCIAS UNIVERSIDAD AUTÓNOMA DE MADRID Identification and functional characterization of epigenetic determinants of pancreatic CSCs Sladjana Zagorac Licenciatura en Biología Molecular y Fisiología Director de Tesis: Prof. Christopher Heeschen, M.D. PhD Centro de células madre en el cáncer y el envejecimiento Barts Instituto de Cancer (BCI) This thesis, submitted for the degree of Doctor of Philosophy at the Universidad Autónoma de Madrid, has been completed in the Stem Cells & Cancer Group at the Spanish National Cancer Research Centre (CNIO) and Centre for Stem Cells in Cancer and Ageing, Barts Cancer Instutute (BCI) under the supervision of Prof. Dr. Christopher Heeschen. Dedicated to my parents, my sister Ivana and my friends who always supported me. ACKNOWLEDGEMENTS It is strange to look back in time and see myself entering true the door of CNIO my first day in Christopher’s laboratory back in October 2010. For some maybe little and for other’s so much. Thank you Christopher for replaying to my email and opening me the door of your lab! It was just a start of an incredible journey that led me where I am now, and that will mark my next trails to run. So many people I need to mention and say thanks for their unconditional help and support. Enza thank you for accepting me as your student and for being patient with me. I will never forget how you would always tell me to think why I am doing things.
    [Show full text]
  • University of Toronto University-Wide Impact Presentation
    UNIVERSITY OF TORONTO UNIVERSITY-WIDE IMPACT PRESENTATION INTRO: .......................................................................................... 2 SECTION 1: GLOBAL FOOTPRINT .............................................. 3 SECTION 2: INNOVATION AND IMPACT .................................... 15 SECTION 3: EXCELLENCE AND LEADERSHIP IN SOCIETY ..... 31 Text is not editable on animation slides. Updated May 2021 ON-SCREEN IMAGE SPEAKER’S NOTES BEGINNING OF PRESENTATION [Good afternoon]. My name is [X], and I serve as [X] at the University of Toronto. Thank you for joining us [today]. [Today] I would like to take you through a presentation that speaks to the crucial role that U of T is honoured to play in our communities and our world. U of T is a world-leading university with three campuses in the Greater Toronto Area. We provide students with a comprehensive global education, produce life-changing research, and promote economic growth and social progress in our communities. I’m going to cover three aspects: • U of T’s Global Footprint • U of T’s Innovation and Impact • U of T’s Excellence and Leadership in Society Since its very early days, U of T has been fortunate to have forged connections with institutions around the world and to have welcomed faculty and students from elsewhere to become part of the U of T community. Today, U of T’s global footprint is significant. 2 SECTION 1 GLOBAL FOOTPRINT 3 ON-SCREEN IMAGE SPEAKER’S NOTES We are immensely proud of our worldwide alumni community. Over 630,000 U of T alumni live, work and contribute to civil society in more than 190 countries and territories. Few universities in the world can rival the cultural diversity of our student population.
    [Show full text]
  • C:\Users\Carolanne\Documents
    If you are having trouble viewing this email, please select here. January 25, 2012 Vol. 20, No. 10 From Banting and Best's discovery of insulin, to Till and McCullough's stem cell breakthrough, the University of Toronto Faculty of Medicine has an incredible legacy of visionary, ground-breaking research. Medical advances traced back to our labs have made countless real-world improvements in patient therapies and care. Together with our TAHSN partners, we truly are a national and international research powerhouse. Ranked 4th for research in Clinical Medicine among World Universities by the Higher Education Council of Taiwan, we are home to 125 Canada Research Chairs, 2 Canada Excellence in Research Chairs, and over 2000 masters and doctoral students who are critical to our research capacity. On January 24, our medical students presented 170 research posters and several oral presentations at their annual research day - a remarkable demonstration of the interest and engagement of our students in scientific enquiry. With the fundamentals in place, there is a tremendous opportunity in Canada to lead the future development of the health research agenda worldwide. But it is not sufficient to do what we have always done. Leadership in the health research of tomorrow will require us to adapt to new realities - where leading-edge investigation takes place across systems and disciplines, and where data can be collected and shared in ways we have not previously envisioned and on a scale we have never before seen. We must create new structures that break down old silos and allow the broad sharing of knowledge.
    [Show full text]
  • Radiation Medicine Program
    Radiation Medicine Program ANNUAL 2020 REPORT 2021 VALUES MISSION Innovation Advance exemplary radiation Excellence medicine through patient Collaboration care, research & education Accountability in partnership with CONTENTS Integrity our patients & community 4 A Message from the Chief 6 Program Overview 7 2020: The Year in Numbers 8 Strategic Roadmap to 2026 VISION 10 Clinical Care CURE EVOLVE 15 Quality & Safety Predictive Health & Precision Radiation Medicine. Advanced Particle Adaptive Radiotherapy Therapy & Theranostics 18 Education Personalized Care. 21 Research Global Impact. 26 Team RMP COMFORT & CONNECT Systems to Maximize CONFIDENCE Innovation & Wellbeing Technology-enabled Patient Experience Transformation A MESSAGE FROM THE CHIEF The Radiation Medicine Program (RMP) at the Princess Margaret Cancer Centre is committed to delivering the highest standard of patient care. Over the RMP’s innovative education programs continue to thrive and attract a diverse group of national and international attendees. Our award-winning Accelerated past year, our dynamic multidisciplinary team of radiation oncologists, medical physicists, radiation therapists, administrators, and support staff have worked Education Program (AEP) demonstrated extraordinary resourcefulness this past year, standing strong amidst the pandemic, and continuing to provide top- together to advance our vision of “Precision Radiation Medicine. Personalized Care. Global Impact.” RMP continues to uphold our foundational values of level education to a broad spectrum of learners.
    [Show full text]
  • Stem Cell Strategy by Establishing the Till & Mcculloch Medicines of Tomorrow Innovation Fund
    A Pre-Budget Submission to the House of Commons Standing Committee on Finance To Implement the Canadian Stem Cell Strategy By Establishing The Till & McCulloch Medicines of Tomorrow Innovation Fund James Price President & CEO Canadian Stem Cell Foundation February 9, 2016 EXECUTIVE SUMMARY Stem cells represent the biggest innovation in medicine of the last half century. These cells have the power to cure many diseases for which current medical practice can only provide symptomatic relief and chronic care – a reality that is straining health care systems in Canada and in countries around the globe. Stem cells are a hallmark of Canadian innovation. They were first discovered in Canada and Canada is one of the top three countries in stem cell R&D, with our scientists ranking among the best in the world. Recent investments, such as the Government’s $20-million commitment to establish a cell-manufacturing facility in Toronto and the $114-million Medicine By Design grant for the University of Toronto, will help Canada move forward. However, major commitments by competitor jurisdictions – most notably California, with its investment of $3 billion, and Japan, with an investment of $1 billion in stem cells and regenerative medicine -- challenge Canada’s leadership in this sector of the knowledge economy. Moreover, Canada lacks a national plan to succeed in the coming cell therapy and regenerative medicine boom. The Canadian Stem Cell Strategy -- created in consultation with 150 scientists, medical doctors, leaders from major health charities, industry experts, investors and philanthropists – will: • deliver up to 10 new curative therapies within 10 years; • transform health care and ease the strain on the health system; and • attract private investment and generate 12,000 jobs for Canadians.
    [Show full text]
  • 1976-77-Annual-Report.Pdf
    TheCanada Council Members Michelle Tisseyre Elizabeth Yeigh Gertrude Laing John James MacDonaId Audrey Thomas Mavor Moore (Chairman) (resigned March 21, (until September 1976) (Member of the Michel Bélanger 1977) Gilles Tremblay Council) (Vice-Chairman) Eric McLean Anna Wyman Robert Rivard Nini Baird Mavor Moore (until September 1976) (Member of the David Owen Carrigan Roland Parenteau Rudy Wiebe Council) (from May 26,1977) Paul B. Park John Wood Dorothy Corrigan John C. Parkin Advisory Academic Pane1 Guita Falardeau Christopher Pratt Milan V. Dimic Claude Lévesque John W. Grace Robert Rivard (Chairman) Robert Law McDougall Marjorie Johnston Thomas Symons Richard Salisbury Romain Paquette Douglas T. Kenny Norman Ward (Vice-Chairman) James Russell Eva Kushner Ronald J. Burke Laurent Santerre Investment Committee Jean Burnet Edward F. Sheffield Frank E. Case Allan Hockin William H. R. Charles Mary J. Wright (Chairman) Gertrude Laing J. C. Courtney Douglas T. Kenny Michel Bélanger Raymond Primeau Louise Dechêne (Member of the Gérard Dion Council) Advisory Arts Pane1 Harry C. Eastman Eva Kushner Robert Creech John Hirsch John E. Flint (Member of the (Chairman) (until September 1976) Jack Graham Council) Albert Millaire Gary Karr Renée Legris (Vice-Chairman) Jean-Pierre Lefebvre Executive Committee for the Bruno Bobak Jacqueline Lemieux- Canadian Commission for Unesco (until September 1976) Lope2 John Boyle Phyllis Mailing L. H. Cragg Napoléon LeBlanc Jacques Brault Ray Michal (Chairman) Paul B. Park Roch Carrier John Neville Vianney Décarie Lucien Perras Joe Fafard Michael Ondaatje (Vice-Chairman) John Roberts Bruce Ferguson P. K. Page Jacques Asselin Céline Saint-Pierre Suzanne Garceau Richard Rutherford Paul Bélanger Charles Lussier (until August 1976) Michael Snow Bert E.
    [Show full text]
  • Killam Prizes | Prix Killam
    Killam Prizes | Prix Killam Year | Winners | University | Discipline Année Gagnants Université 2021 Michel Bouvier Université de Montréal Health Sciences | sciences de la santé Stephen R. Gill York University Social Sciences | sciences sociales Gilbert Laporte HEC Montréal Engineering | génie Arthur Ripstein University of Toronto Humanities | sciences humaines Douglas Stephan University of Toronto Natural Sciences | sciences de la nature 2020 Cecilia Benoit University of Victoria Social Sciences | sciences sociales Sarah Carter University of Alberta Humanities | sciences humaines Alan Evans Montreal Neurological Institute Health Sciences | sciences de la santé Ted Sargent University of Toronto Engineering | génie Barbara Sherwood Lollar University of Toronto Natural Sciences | sciences de la nature 2019 Yoshua Bengio Université de Montréal Natural Sciences | sciences de la nature André Blais Université de Montréal Social Sciences | sciences sociales Keith W. Hipel University of Waterloo Engineering | génie Stephen W. Scherer University of Toronto Health Sciences | sciences de la santé Lynne Viola University of Toronto Humanities | sciences humaines 2018 André Gaudreault Université de Montréal Humanities | sciences humaines Vladimir Hachinski Western University Health Sciences | sciences de la santé Walter Herzog University of Calgary Engineering | génie James Pinfold University of Alberta Natural Sciences | sciences de la nature Janet Werker University of British Columbia Social Sciences | sciences sociales Canada Council for the Arts
    [Show full text]
  • By the Numbers Excellence, Innovation, Leadership: Research at the University of Toronto a Powerful Partnership
    BY THE NUMBERS EXCELLENCE, INNOVATION, LEADERSHIP: RESEARCH AT THE UNIVERSITY OF TORONTO A POWERFUL PARTNERSHIP The combination of U of T and the 10 partner hospitals affiliated with the university creates one of the world’s largest and most innovative health research forces. More than 1,900 researchers and over 4,000 graduate students and postdoctoral fellows pursue the next vital steps in every area of health research imaginable. UNIVERSITY OF TORONTO Sunnybrook Health St. Michaelʼs Sciences Centre Hospital Womenʼs College Bloorview Kids Hospital Rehab A POWERFUL PARTNERSHIP Baycrest Mount Sinai Hospital The Hospital University Health for Sick Children Network* Centre for Toronto Addiction and Rehabilitation Mental Health Institute *Composed of Toronto General, Toronto Western and Princess Margaret Hospitals 1 UNIVERSITY OF TORONTO FACULTY EXCELLENCE U of T researchers consistently win more prestigious awards than any other Canadian university. See the end of this booklet for a detailed list of awards and honours received by our faculty in the last three years. Faculty Honours (1980-2009) University of Toronto compared to awards held at other Canadian universities International American Academy of Arts & Sciences* Gairdner International Award Guggenheim Fellows National Academies** Royal Society Fellows Sloan Research Fellows American Association for the Advancement of Science* ISI Highly-Cited Researchers*** 0 20 40 60 801 00 Percentage National Steacie Prize Molson Prize Federal Granting Councilsʼ Highest Awards**** Killam Prize Steacie
    [Show full text]
  • Printable List of Laureates
    Laureates of the Canadian Medical Hall of Fame A E Maude Abbott MD* (1994) Connie J. Eaves PhD (2019) Albert Aguayo MD(2011) John Evans MD* (2000) Oswald Avery MD (2004) F B Ray Farquharson MD* (1998) Elizabeth Bagshaw MD* (2007) Hon. Sylvia Fedoruk MA* (2009) Sir Frederick Banting MD* (1994) William Feindel MD PhD* (2003) Henry Barnett MD* (1995) B. Brett Finlay PhD (2018) Murray Barr MD* (1998) C. Miller Fisher MD* (1998) Charles Beer PhD* (1997) James FitzGerald MD PhD* (2004) Bernard Belleau PhD* (2000) Claude Fortier MD* (1998) Philip B. Berger MD (2018) Terry Fox* (2012) Michel G. Bergeron MD (2017) Armand Frappier MD* (2012) Alan Bernstein PhD (2015) Clarke Fraser MD PhD* (2012) Charles H. Best MD PhD* (1994) Henry Friesen MD (2001) Norman Bethune MD* (1998) John Bienenstock MD (2011) G Wilfred G. Bigelow MD* (1997) William Gallie MD* (2001) Michael Bliss PhD* (2016) Jacques Genest MD* (1994) Roberta Bondar MD PhD (1998) Gustave Gingras MD* (1998) John Bradley MD* (2001) Phil Gold MD PhD (2010) Henri Breault MD* (1997) Richard G. Goldbloom MD (2017) G. Malcolm Brown PhD* (2000) Jean Gray MD (2020) John Symonds Lyon Browne MD PhD* (1994) Wilfred Grenfell MD* (1997) Alan Burton PhD* (2010) Gordon Guyatt MD (2016) C H G. Brock Chisholm MD (2019) Vladimir Hachinski MD (2018) Harvey Max Chochnov, MD PhD (2020) Antoine Hakim MD PhD (2013) Bruce Chown MD* (1995) Justice Emmett Hall* (2017) Michel Chrétien MD (2017) Judith G. Hall MD (2015) William A. Cochrane MD* (2010) Michael R. Hayden MD PhD (2017) May Cohen MD (2016) Donald O.
    [Show full text]
  • 2011/2012 Annual Report
    BUILDINGALEGACY Stem Cell Network 2011-2012 Annual Report StemCell Network 2011-2012 Annual Report TABLE OF CONTENTS Directors’ Message .........................................................................................2 Bridging The Translational Gap ...................................................................4 In Profile: Dr. Denis-Claude Roy .............................................7 The High-Throughput Revolution................................................................8 In Profile: Dr. Aaron Schimmer .........................................11 See The Potential: An Industry-Academia Hybrid ...............................12 In Profile: Dr. Corinne Hoesli ..............................................14 A Research Conference Built by the Community .................................15 In Profile: Dr. Peter Zandstra .............................................17 Building an Informed Public.......................................................................18 In Profile: Angela McDonald .............................................21 Network Community ...................................................................................22 2011-12 Financial Statements ...................................................................25 Directors’ Message Message from SCN’s Board Chair, Scientific Director, and Executive Director t’s year 12. On paper, the Stem Cell Network has entered its for blood cancers at the University of Montréal. Dr. Roy’s project, sunset years, but we’re not ready to rest on our laurels
    [Show full text]
  • NEWSBRIEFS I Five Physicians Chosen for Order of Canada
    NEWSBRIEFS I Five physicians chosen for Order of Canada Canada's highest distinction Dr. Wilson, nominated as one of Dr. Germain Bigue, born in awarded in recognition 17 new officers, was born in Ed- Saint-Thcle, Quebec in 1912, will monton in 1913, and has had a become a member of the Order. of outstanding achievement lifetime involvement with medical Dr. Bigu. has devoted considerable and service. education in this country; from skill and energy to improving the 1968-78 he served as director of health services in the Val d'Or re- "I don't do post-mortems on emo- the R.S. McLaughlin examination gion: he opened a clinic for the tions", commented Dr. Donald and research centre of the Royal workers at the Lamaque and Sigma Wilson of Edmonton, "but I College of Physicians and Surgeons, mines in the 1950s; served as chief couldn't help being pleased and sur- and was instrumental in ensuring of surgical services at St-Sauveur prised when I heard this was in the that all doctors, wherever they had Hospital from 1955-1965 and sub- wind. And humbled - because trained, were tested to the same sequently as director of professional there are so many great Canadians levels of excellence and compe- services from 1970-78; established who don't get on the Governor tence. the first blood bank and a division General's list." Among his several other accom- of the Canadian Cancer Society in Dr. Wilson is one of five physi- plishments, from 1954-68 Dr. Wil- the area; and is active in commu- cians among the 57 Canadians re- son was professor and chairman of nity affairs ranging from the Val cently appointed to the Order of the University of Alberta's depart- d'Or Historical Society to the Val Canada, the highest distinction in ment of medicine, from 1978-80 d'Or senior citizens' home.
    [Show full text]